Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H35N3O2 |
Molecular Weight | 421.575 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC1=C(C=CC=C1)N2CCN(CC3=CC=CC(=C3)C(=O)N4CCCCC4)CC2
InChI
InChIKey=ZKZFPRUSWCYSGT-UHFFFAOYSA-N
InChI=1S/C26H35N3O2/c1-21(2)31-25-12-5-4-11-24(25)28-17-15-27(16-18-28)20-22-9-8-10-23(19-22)26(30)29-13-6-3-7-14-29/h4-5,8-12,19,21H,3,6-7,13-18,20H2,1-2H3
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8681493
healthy male subjects received incremental oral doses of mazapertine (from 5 to 50 mg over 7 days; n = 10) or placebo (n = 3) in part I and single doses in parts II (20 or 30 mg or placebo) and III (40 mg or placebo) in a double-blind fashion.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7300
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
N0X1XW704P
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
SUB08654MIG
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
134208-17-6
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
100000081746
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
MAZAPERTINE
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
C174731
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
60820
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
DTXSID40158594
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL10085
Created by
admin on Fri Dec 15 17:19:13 GMT 2023 , Edited by admin on Fri Dec 15 17:19:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)